An eco-friendly and green formulation in lipid nanotechnology for delivery of a hydrophilic agent to the skin in the treatment and management of hyperpigmentation complaints: Arbutin niosome (Arbusome).
暂无分享,去创建一个
[1] J. Akbari,et al. Topical Gel of Vitamin A Solid Lipid Nanoparticles: A Hopeful Promise as a Dermal Delivery System , 2020, Advanced pharmaceutical bulletin.
[2] J. Akbari,et al. Curcumin Niosomes (curcusomes) as an alternative to conventional vehicles: A potential for efficient dermal delivery , 2020 .
[3] J. Akbari,et al. Innovation of testosome as a green formulation for the transdermal delivery of testosterone enanthate , 2020, Journal of Drug Delivery Science and Technology.
[4] Famna Roohi N K,et al. Development and evaluation of medicated cosmetic cream to produce triple effect on skin for the treatment of uneven skin tone , 2020 .
[5] J. Akbari,et al. An emerging technology in lipid research for targeting hydrophilic drugs to the skin in the treatment of hyperpigmentation disorders: kojic acid-solid lipid nanoparticles , 2020, Artificial cells, nanomedicine, and biotechnology.
[6] Sunil Kumar,et al. Microsponges for dermatological applications: Perspectives and challenges , 2019, Asian journal of pharmaceutical sciences.
[7] Y. Boo. p-Coumaric Acid as An Active Ingredient in Cosmetics: A Review Focusing on its Antimelanogenic Effects , 2019, Antioxidants.
[8] Hyo-Jong Lee,et al. Synthesis of arbutin–gold nanoparticle complexes and their enhanced performance for whitening , 2019, Archives of Pharmacal Research.
[9] J. Akbari,et al. Topical gel of Metformin solid lipid nanoparticles: A hopeful promise as a dermal delivery system. , 2019, Colloids and surfaces. B, Biointerfaces.
[10] Z. Hussain,et al. Polymeric nanoparticles for topical delivery of alpha and beta arbutin: preparation and characterization , 2019, Drug Delivery and Translational Research.
[11] V. Mishra,et al. Solid Lipid Nanoparticles: Emerging Colloidal Nano Drug Delivery Systems , 2018, Pharmaceutics.
[12] Wei Xu,et al. DeepScreen: An Accurate, Rapid, and Anti‐Interference Screening Approach for Nanoformulated Medication by Deep Learning , 2018, Advanced science.
[13] M. Helder,et al. Overview of preparation methods of polymeric and lipid-based (niosome, solid lipid, liposome) nanoparticles: A comprehensive review , 2018 .
[14] E. Mazzotta,et al. Innovative topical formulations from diclofenac sodium used as surfadrug: The birth of Diclosomes. , 2018, Colloids and surfaces. B, Biointerfaces.
[15] Sri Luliana,et al. In vitro penetration of alpha arbutin niosome span 60 system in gel preparation , 2017 .
[16] F. Din,et al. Proniosomes derived niosomes: recent advancements in drug delivery and targeting , 2017, Drug delivery.
[17] G. Rajabzadeh,et al. Physicochemical properties and release behavior of Span 60/Tween 60 niosomes as vehicle for α-Tocopherol delivery , 2017 .
[18] I. Kohli,et al. Postinflammatory hyperpigmentation: A comprehensive overview: Epidemiology, pathogenesis, clinical presentation, and noninvasive assessment technique. , 2017, Journal of the American Academy of Dermatology.
[19] Xuan Chen,et al. Structural characterization of inclusion complex of arbutin and hydroxypropyl-β-cyclodextrin , 2016 .
[20] J. Akbari,et al. The design of naproxen solid lipid nanoparticles to target skin layers. , 2016, Colloids and surfaces. B, Biointerfaces.
[21] D. Daulatabad,et al. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies , 2016, Indian journal of dermatology, venereology and leprology.
[22] J. Varshosaz,et al. Effect of different types of surfactants on the physical properties and stability of carvedilol nano-niosomes , 2016, Advanced biomedical research.
[23] Gaurav Chauhan,et al. Development and characterization of niosomal gel for topical delivery of benzoyl peroxide , 2015, Drug delivery.
[24] M. Sasidharan,et al. Self-degrading niosomes for encapsulation of hydrophilic and hydrophobic drugs: An efficient carrier for cancer multi-drug delivery. , 2015, Materials science & engineering. C, Materials for biological applications.
[25] S. Emami,et al. Kojic acid-derived tyrosinase inhibitors: synthesis and bioactivity , 2015 .
[26] H. Maibach,et al. Animal models for percutaneous absorption , 2015, Journal of applied toxicology : JAT.
[27] Y. Niwano,et al. Alleviation effect of arbutin on oxidative stress generated through tyrosinase reaction with l-tyrosine and l-DOPA , 2014, BMC Biochemistry.
[28] F. Rinaldi,et al. Niosomes from 80s to present: the state of the art. , 2014, Advances in colloid and interface science.
[29] A. Katsambas,et al. Pigmentation disorders: hyperpigmentation and hypopigmentation. , 2014, Clinics in dermatology.
[30] S. Nakata,et al. Analysis of the effects of hydroquinone and arbutin on the differentiation of melanocytes. , 2013, Biological & pharmaceutical bulletin.
[31] P. Fong,et al. In Silico Prediction of the Cosmetic Whitening Effects of Naturally Occurring Lead Compounds , 2012, Natural product communications.
[32] R. Muzzalupo,et al. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin. , 2011, Colloids and surfaces. B, Biointerfaces.
[33] Erica C Davis,et al. Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. , 2010, The Journal of clinical and aesthetic dermatology.
[34] N. Polnikorn. Treatment of refractory melasma with the MedLite C6 Q-switched Nd:YAG laser and alpha arbutin: A prospective study , 2010, Journal of cosmetic and laser therapy : official publication of the European Society for Laser Dermatology.
[35] S. Talegaonkar,et al. Niosomes in sustained and targeted drug delivery: some recent advances , 2009, Journal of drug targeting.
[36] C. Pirker,et al. The sodium pump α1 sub-unit: a disease progression–related target for metastatic melanoma treatment , 2009, Journal of cellular and molecular medicine.
[37] B. Kıvçak,et al. Efficiency of ellagic acid and arbutin in melasma: A randomized, prospective, open‐label study , 2008, The Journal of dermatology.
[38] O. Sammour,et al. Effect of some formulation parameters on flurbiprofen encapsulation and release rates of niosomes prepared from proniosomes. , 2008, International journal of pharmaceutics.
[39] Wen‐yuan Zhu,et al. The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. , 2008, The journal of investigative dermatology. Symposium proceedings.
[40] Biana Godin,et al. Transdermal skin delivery: predictions for humans from in vivo, ex vivo and animal models. , 2007, Advanced drug delivery reviews.
[41] I. Duarte,et al. Frequency of dermatoses associated with cosmetics , 2007, Contact dermatitis.
[42] Yoon-Sik Lee,et al. Kojic acid-tripeptide amide as a new tyrosinase inhibitor. , 2007, Biopolymers.
[43] A. Fadda,et al. Niosomes as carriers for tretinoin. III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. , 2006, International journal of pharmaceutics.
[44] B. Nasseri. Effect of cholesterol and temperature on the elastic properties of niosomal membranes. , 2005, International journal of pharmaceutics.
[45] S. Mutalik,et al. Glibenclamide transdermal patches: physicochemical, pharmacodynamic, and pharmacokinetic evaluations. , 2004, Journal of pharmaceutical sciences.
[46] A. Pardakhty,et al. Development and Physical Characterization of Sorbitan Monoester Niosomes for Insulin Oral Delivery , 2003, Drug delivery.
[47] N. Jain,et al. Liquid crystalline pharmacogel based enhanced transdermal delivery of propranolol hydrochloride. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[48] JAN PŘBORSKÝ,et al. Evaluation of In‐vitro Percutaneous Absorption across Human Skin and in Animal Models , 1990, The Journal of pharmacy and pharmacology.
[49] J. Fulton,et al. Studies on the Mechanism of Action of Topical Benzoyl Peroxide and Vitamin A Acid in Acne Vulgaris , 1974, Journal of cutaneous pathology.